Impact of Src homology 2-containing inositol 5′-phosphatase 2 gene polymorphisms detected in a Japanese population on insulin signaling

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 5, 2005, Pages 2911-2919

  Kagawa, Syota ^a   Sasaoka, Toshiyasu ^a   Yaguchi, Saori ^a   Ishihara, Hajime ^b   Tsuneki, Hiroshi ^a   Murakami, Shihou ^a   Fukui, Kazuhito ^a   Wada, Tsutomu ^a   Kobayashi, Soushi ^a   Kimura, Ikuko ^a   Kobayashi, Masashi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Sainou Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4 BISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHOTYROSINE; PROTEIN KINASE B BETA; PROTEIN SH2; PROTEIN SHC; SRC HOMOLOGY 2 CONTAINING INOSITOL 5' PHOSPHATASE 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHO CELL; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVATION; FEMALE; GENETIC TRANSFECTION; HUMAN; INSULIN RESISTANCE; JAPAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; FEMALE; HAPLOTYPES; HUMANS; INOSITOL PHOSPHATES; INSULIN; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 21044450947     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1724     Document Type: Article

References (40)

1. Virkamäki A, Ueki K, Kahn CR 1999 Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103:931-943
2. Pessin JE, Saltiel AR 2000 Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 106:165-169
3. Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P, Lauro R 2001 Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J 15:2099-2111
4. Saltiel AR, Kahn CR 2001 Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806
5. Czech MP, Corvera S 1999 Signaling mechanisms that regulate glucose transport. J Biol Chem 274:1865-1868
6. Rameh LE, Cantley LC 1999 The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem 274:8347-8350
7. Fruman DA, Rameh LE, Cantley LC 1999 Phosphoinositide binding domains: embracing 3-phosphate. Cell 97:817-820
8. Vanhaesebroeck B, Alessi DR 2000 The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346:561-576
9. Farese RV 2002 Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states. Am J Physiol Endocrinol Metabol 283:E1-E11
10. Pesesse X, Deleu S, De Smedt F, Drayer L, Erneux C 1997 Identification of a second SH2-domain-containing protein closely related to the phosphatidyl-inositol polyphosphate 5-phosphatase SHIP. Biochem Biophys Res Commun 239:697-700
11. Ishihara H, Sasaoka T, Hori H, Wada T, Hirai H, Haruta T, Langlois WJ, Kobayashi M 1999 Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling. Biochem Biophys Res Commun 260:265-272
12. Wada T, Sasaoka T, Funaki M, Hori H, Murakami S, Ishiki M, Haruta T, Asano T, Ogawa W, Ishihara H, Kobayashi M 2001 Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5′-phosphatase catalytic activity. Mol Cell Biol 21:1633-1646
13. Sasaoka T, Hori H, Wada T, Ishiki M, Haruta T, Ishihara H, Kobayashi M 2001 SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes. Diabetologia 44:1258-1267
14. Vollenweider P, Clodi M, Martin SS, Imamura T, Kavanaugh WM, Olefsky JM 1999 An SH2 domain-containing 5′ inositol phosphatase inhibits insulin-induced GLUT4 translocation and growth factor-induced actin filament rearrangement. Mol Cell Biol 19:1081-1091
15. Clément S, Krause U, Desmedt F, Tanti J-F, Behrends J, Pesesse X, Sasaki T, Penninger J, Doherty M, Malaisse W, Dumont JE, Le Marchand-Brustel Y, Erneux C, Hue L, Schurmans S 2001 The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 409:92-97
16. Hori H, Sasaoka T, Ishihara H, Wada T, Murakami S, Ishiki M, Kobayashi M 2002 Association of SH2-containing inositol phosphatase 2 with the insulin resistance of diabetic db/db mice. Diabetes 51:2387-2394
17. Xu X, Rogus JJ, Terwedow HA, Yang J, Wang Z, Chen C, Niu T, Wang B, Xu H, Weiss S, Schork NJ, Fang Z 1999 An extreme-sib-pair genome scan for genes regulating blood pressure. Am J Hum Genet 64:1694-1701
18. Panhuysen CI, Cupples LA, Wilson PW, Herbert AG, Myers RH, Meigs JB 2003 A genome scan for loci linked to quantitative insulin traits in persons without diabetes: the Framingham Offspring Study. Diabetologia 46:579-587
19. Silander K, Scott LJ, Valle TT, Mohlke KL, Stringham HM, Wiles KR, Duren WL, Doheny KF, Pugh EW, Chines P, Narisu N, White PP, Fingerlin TE, Jackson AU, Li C, Ghosh S, Magnuson VL, Colby K, Erdos MR, Hill JE, Hollstein P, Humphreys KM, Kasad RA, Lambert J, Lazaridis KN, Lin G, Morales-Mena A, Patzkowski K, Pfahl C, Porter R, Rha D, Segal L, Suh YD, Tovar J, Unni A, Welch C, Douglas JA, Epstein MP, Hauser ER, Hagopian W, Buchanan TA, Watanabe RM, Bergman RN, Tuomilehto J, Collins FS, Boehnke M 2004 A large set of Finnish affected sibling pair families with type 2 diabetes suggests susceptibility loci on chromosomes 6,11, and 14. Diabetes 53:821-829
20. Marion E, Kaisaki PJ, Pouillon V, Gueydan C, Levy JC, Bodson A, Krzentowski G, Daubresse J-C, Mockel J, Behrends J, Servais G, Szpirer C, Kruys V, Gauguier D, Schurmans S 2002 The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man. Diabetes 51:2012-2017
21. Kaisaki PJ, Délepine M, Woon PY, Sebag-Montefiore L, Wilder SP, Menzel S, Vionnet N, Marion E, Riveline J-P, Charpentier G, Schurmans S, Levy JC, Lathrop M, Farrall M, Gauguier D 2004 Polymorphisms in type II SH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome. Diabetes 53:1900-1904
22. Alberti KG, Zimmet PZ 1998 Definition, diagnosis and classification of diabetes mellitus and its complications: 1. diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med 15:539-553
23. Matsuoka N, Ogawa Y, Hosoda K, Matsuda J, Masuzaki H, Miyawaki T, Azuma N, Natsui K, Nishimura H, Yoshimasa Y, Nishi S, Thompson DB, Nakao K 1997 Human leptin receptor gene in obese Japanese subjects: evidence against either obesity-causing mutations or association of sequence variants with obesity. Diabetologia 40:1204-1210
24. Takata M, Ogawa W, Kitamura T, Hino Y, Kuroda S, Kotani K, Klip A, Gingras A-C, Sonenberg N, Kasuga M 1999 Requirement for Akt (protein kinase B) in insulin-induced activation of glycogen synthase and phosphorylation of 4E-BP1 (PHAS-1). J Biol Chem 274:20611-20618
25. Niswender KD, Gallis B, Blevins JE, Corson MA, Schwartz MW, Baskin DG 2003 Immunocytochemical detection of phosphatidylinositol 3-kinase activation by insulin and leptin. J Histochem Cytochem 51:275-283
26. Excoffier L, Slatkin M 1995 Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12:921-927
27. Hajduch E, Litherland GJ, Hundal HS 2001 Protein kinase B (PKB/Akt)-a key regulator of glucose transport? FEBS Lett 492:199-203
28. Katome T, Obata T, Matsushima R, Masuyama N, Cantley LC, Gotoh Y, Kishi K, Shiota H, Ebina Y 2003 Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/protein kinase B isoforms in insulin actions. J Biol Chem 278:28312-28323
29. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ 2001 Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276:38349-38352
30. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB 3rd, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ 2001 Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 292:1728-1731
31. Ishihara H, Sasaoka T, Ishiki M, Wada T, Hori H, Kagawa S, Kobayashi M 2002 Membrane localization of Src homology 2-containing inositol 5′-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors. Mol Endocrinol 16:2371-2381
32. He W, O'Neill TJ, Gustafson TA 1995 Distinct modes of interaction of SHC and insulin receptor substrate-1 with the insulin receptor NPEY region via non-SH2 domains. J Biol Chem 270:23258-23262
33. Paez-Espinosa V, Carvalho CR, Alvarez-Rojas F, Janeri L, Velloso LA, Boschero AC, Saad MJ 1998 Insulin induces tyrosine phosphorylation of Shc and stimulates Shc/GRB2 association in insulin-sensitive tissues of the intact rat. Endocrine 8:193-200
34. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, Kadowaki H, Hagura R, Akanuma Y, Yazaki Y, Nagai R, Taniyama M, Matsubara K, Yoda M, Nakano Y, Kimura S, Tomita M, Kimura S, Ito C, Froguel P, Kadowaki T 2002 Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51:536-540
35. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, Boutin P, Vaxillaire M, Leprêtre F, Dupont S, Hara K, Clement K, Bihain B, Kadowaki T, Froguel P 2002 Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11:2607-2614
36. Hanada M, Feng J, Hemmings BA 2004 Structure, regulation and function of PKB/AKT-a major therapeutic target. Biochim Biophys Acta 1697:3-16
37. Jiang ZY, Zhou QL, Coleman KA, Chouinard M, Boese Q, Czech MP 2003 Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc Natl Acad Sci USA 100:7569-7574
38. Sasaoka T, Wada T, Fukui K, Murakami S, Ishihara H, Suzuki R, Tobe K, Kadowaki T, Kobayashi M 2004 SH2-containing inositol phosphatase 2 pre-dominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes. J Biol Chem 279: 14835-14843
39. Begum N, Song Y, Rienzie J, Ragolia L 1998 Vascular smooth muscle cell growth and insulin regulation of mitogen-activated protein kinase in hypertension. Am J Physiol Cell Physiol 275:C42-C49
40. Antonarakis SE 1998 Recommendations for a nomenclature system for human gene mutations. Hum Mutat 11:1-3